Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. September 2022 07:00 ET | Quelle: Lucira Health Inc.

Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays

EMERYVILLE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health” or “Lucira”), a medical technology company, today announced interim results of a pilot...
29. September 2022 07:00 ET | Quelle: C4 Therapeutics, Inc.

C4 Therapeutics Receives Study May Proceed Letter from U.S. FDA to Initiate Phase 1/2 Clinical Trial of CFT1946, an Orally Bioavailable BiDAC™ Degrader, in BRAF-V600 Mutant Solid Cancers

WATERTOWN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation...
29. September 2022 07:00 ET | Quelle: EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 PAVIA Clinical Trial of EYP-1901 for the Treatment of Non-Proliferative Diabetic Retinopathy

WATERTOWN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the...
29. September 2022 06:30 ET | Quelle: Grow Up Conference and Expo

Grow Up Conference and Expo Wraps Up in Niagara Falls

Niagara Falls, ON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Grow Up Conference and Expo (“Grow Up”) has completed its sixth annual event based in Niagara Falls, this year being held from Sunday, September...
29. September 2022 06:00 ET | Quelle: Galecto, Inc.

GB2064 Shows Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis, Validating LOXL2 as a Clinical Fibrosis Target

BOSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today...
29. September 2022 05:10 ET | Quelle: Global Market Insights Inc.

Demulcent Eye Drops Market to hit USD 3 billion by 2030, says Global Market Insights Inc.

Selbyville, Delaware, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The demulcent eye drops market value is set to surpass USD 3 billion by 2030, according to a new research report by Global Market Insights...
29. September 2022 05:01 ET | Quelle: NutriLeads

NutriLeads Consumer Insights Report Shows Consumer Perceptions Fundamentally Changed Through the Pandemic

WAGENINGEN, The Netherlands, Sept. 29, 2022 (GLOBE NEWSWIRE) -- NutriLeads BV, a health ingredients company, launched a new consumer insights report today which shows that consumer views on immune...
29. September 2022 02:30 ET | Quelle: Market Research Future

Heart Tumor Market Size Worth USD 1.36 Billion by 2030 at 8.5% CAGR - Report by Market Research Future (MRFR)

New York, USA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Heart Tumor Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Heart Tumor Market Information By...
29. September 2022 01:10 ET | Quelle: Adroit Market Research

Pet Insurance Market to grow at 11.5% CAGR to hit $39.6 Bn by 2030 – Size, Growth Rate, Top Companies, 2022 Trends, Technological Development, Australian Market Analysis, Regulatory Landscape, and Business Prospect - Adroit Market Research

Dallas, Texas, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The global pet insurance market is progressing mostly due to the rising adoption of pets and greater public awareness of pet insurance. In recent...
28. September 2022 16:32 ET | Quelle: Aligos Therapeutics

Aligos Therapeutics Files Response to Janssen Biopharma Lawsuit and Lodges Counterclaims Alleging Unfair Competition and Promissory Fraud

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to...

Vorherige Seite

Nächste Seite